Scott B. Ullem, CVP, Chief Financial Officer at Edwards Lifesciences Corp (EW), sold 29,020 shares at $76.55 ($2.2M) on 2023-12-29, disclosed to the SEC on 2023-12-29.
Scheduled sale ($2.2M) by CVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.55 | 14,510 | $1.1M | 50.0% |
| 2 | $76.55 | 14,510 | $1.1M | 50.0% |
| Total | $76.55 avg | 29,020 | $2.2M | 100% |
| Filing → |
| EW | SELL | 2025-12-09 | $650K | — | Filing → |
| EW | SELL | 2025-11-10 | $2.2M | — | Filing → |
| EW | SELL | 2025-05-09 | $1.7M | — | Filing → |